Ullah M, Yang X, Zhang Z, Wu T, Zhao N, Guan L
IEEE Open J Eng Med Biol. 2025; 6:241-247.
PMID: 39906267
PMC: 11793861.
DOI: 10.1109/OJEMB.2024.3506914.
Chatzimichail T, Hatjimihail A
BMC Med Inform Decis Mak. 2024; 24(1):399.
PMID: 39709395
PMC: 11662465.
DOI: 10.1186/s12911-024-02721-x.
Epelde F
Pathogens. 2024; 13(11).
PMID: 39599493
PMC: 11597561.
DOI: 10.3390/pathogens13110940.
Duesterwald L, Nguyen M, Christensen P, Long S, Olsen R, Musser J
PLoS One. 2024; 19(10):e0312686.
PMID: 39475880
PMC: 11524481.
DOI: 10.1371/journal.pone.0312686.
Kumar S, Nan L, Kalodimou G, Jany S, Freudenstein A, Brandmuller C
Int J Mol Sci. 2024; 25(20).
PMID: 39456680
PMC: 11508112.
DOI: 10.3390/ijms252010898.
Prevalence of SARS-CoV-2 virus in saliva, stool, and urine samples of COVID-19 patients in Bihar, India.
Meghna N, Archana A, Bhushan D, Kumar A, Sarfraz A, Naik B
Access Microbiol. 2024; 6(6).
PMID: 39045236
PMC: 11261694.
DOI: 10.1099/acmi.0.000693.v4.
Clinical Significance of Quantitative Viral Load in Patients Positive for SARS-CoV-2.
Finks S, Van Matre E, Budd W, Lemley E, Ray N, Mahon M
Am J Med Open. 2024; 10:100050.
PMID: 39035250
PMC: 11256246.
DOI: 10.1016/j.ajmo.2023.100050.
Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19.
Li Y, Lu S, Wang J, Yao H, Liang L
Heliyon. 2024; 10(12):e33179.
PMID: 39021908
PMC: 11253070.
DOI: 10.1016/j.heliyon.2024.e33179.
Assessment of COVID-19 risk factors of early and long-term mortality with prediction models of clinical and laboratory variables.
Lipski D, Radziemski A, Wasiliew S, Wyrwa M, Szczepaniak-Chichel L, Stryczynski L
BMC Infect Dis. 2024; 24(1):685.
PMID: 38982355
PMC: 11234702.
DOI: 10.1186/s12879-024-09592-7.
Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study.
Bailon-Cuenca J, Cortes-Sarabia K, Legorreta-Soberanis J, Alvarado-Castro V, Juarez-Baltazar U, Sanchez-Gervacio B
BMC Infect Dis. 2024; 24(1):584.
PMID: 38867165
PMC: 11170790.
DOI: 10.1186/s12879-024-09435-5.
A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.
Chavda V, Yadav D, Parmar H, Brahmbhatt R, Patel B, Madhwani K
Curr Top Med Chem. 2024; 24(21):1883-1916.
PMID: 38859776
DOI: 10.2174/0115680266296095240529114058.
An alternative method for SARS-CoV-2 detection with use modified fluorescent in situ hybridization.
Sroka-Oleksiak A, Krawczyk A, Talaga-Cwiertnia K, Salamon D, Brzychczy-Wloch M, Gosiewski T
AMB Express. 2024; 14(1):64.
PMID: 38842570
PMC: 11156814.
DOI: 10.1186/s13568-024-01726-z.
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R
Vaccines (Basel). 2024; 12(5).
PMID: 38793710
PMC: 11125746.
DOI: 10.3390/vaccines12050459.
Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies.
Almulla N, Soltane R, Alasiri A, Kamal Allayeh A, Alqadi T, Alshehri F
Heliyon. 2024; 10(9):e29909.
PMID: 38707469
PMC: 11068538.
DOI: 10.1016/j.heliyon.2024.e29909.
Clinical Evaluation of Commercial HARDSON COVID-19 Antigen Rapid Test Kit for Routine COVID-19 Diagnosis.
Kakhki R, Neshani A, Kakhki M, Zare H
Infect Dis Clin Microbiol. 2024; 5(2):113-117.
PMID: 38633014
PMC: 10986721.
DOI: 10.36519/idcm.2023.224.
P-FAB: A Fiber-Optic Biosensor Device for Rapid Detection of COVID-19.
Murugan D, Bhatia H, Sai V, Satija J
Trans Indian Natl Acad Eng. 2024; 5(2):211-215.
PMID: 38624432
PMC: 7301353.
DOI: 10.1007/s41403-020-00122-w.
Use of Conventional Chest Imaging and Artificial Intelligence in COVID-19 Infection. A Review of the Literature.
Corbacho Abelaira M, Corbacho Abelaira F, Ruano-Ravina A, Fernandez-Villar A
Open Respir Arch. 2024; 3(1):100078.
PMID: 38620646
PMC: 7834680.
DOI: 10.1016/j.opresp.2020.100078.
Advances and Challenges in SARS-CoV-2 Detection: A Review of Molecular and Serological Technologies.
El-Daly M
Diagnostics (Basel). 2024; 14(5).
PMID: 38472991
PMC: 10931201.
DOI: 10.3390/diagnostics14050519.
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine.
Espino A, Armina-Rodriguez A, Alvarez L, Ocasio-Malave C, Ramos-Nieves R, Rodriguez Martino E
Viruses. 2024; 16(2).
PMID: 38399963
PMC: 10893502.
DOI: 10.3390/v16020187.
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.
Martinez-Lopez J, DE LA Cruz J, Gil-Manso R, Jimenez Yuste V, Aspa-Cilleruelo J, Escobar C
Cancers (Basel). 2024; 16(2).
PMID: 38254867
PMC: 10814951.
DOI: 10.3390/cancers16020379.